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Summary: Measurements of -amylase with 4-nitrophenyl glucosides offer the following advantages over
methods that rely on the formation of NADH:
a short lag phase, no apparent interference by metabolites and enzymes of the sample and extremely stable
Substrates with low blank values. The intrinsic sensitivity of nitrophenyl formation was equal to that of hydroly-
sis of maltotetraose, but was less than that of glucose-producing methods using oligosaccharides. In contrast to
starch, the chromogenic Substrates are more rapidly hydrolysed by salivary than by pancreatic amylase.
Disadvantages of these Substrates are:
higher turnover by animal than by human amylases, and a marked susceptibility of the chromophore to small
changes of pH and protein concentration. Some analytical qualities such äs specificity, accuracy, precision,
stability of the Substrate and linear ränge are described in detail and compared with those of other methods.
Bewertung von Methoden zur Bestimmung von a-Amylase
mit 4-Nitrophenyl-a-oligosacchariden als Substraten
Zusammenfassung: -Amylase-Bestimmungen mit 4-NitrophenyIglucosiden sind Methoden, die auf einer
Reduktion von NAD beruhen, durch eine kürzere lag phase, fehlende Störung durch Metaboliten und Enzyme
der Probe und durch außerordentlich haltbare Substrate mit niedriger Leerreaktion überlegen. Die Empfind-
lichkeit der Nitrophenolbildung entspricht der Spaltung von Maltotetraose, sie bleibt jedoch hinter dem Entste-
hen von Glucose aus Oligosacchariden zurück. Im Gegensatz zu Stärke werden die chromogenen Substrate
schneller durch Speichel- als durch Pankreasamylase abgebaut.
Nachteile ihrer Verwendung sind ein höherer Umsatz durch Amylasen tierischer Herkunft im Vergleich zu
menschlichen Enzymen und der starke Einfluß geringer Veränderungen der Proteinkonzentration und des pH-
Wertes im Ansatz. Im einzelnen werden die Spezifität, Richtigkeit und Präzision dieser Verfahren, die Haltbar-
keit ihrer Substrate, der lineare Meßbereich und ein Vergleich mit anderen Methoden beschrieben.
Introduction
The growing number of continuous measurement
techniques for the determination of a-amylase (1,4-
a-D-glucan glucanohydrolase, EC 3.2.1-1) activity
has been increased by the development of chromo-
genic methods based on the retease of 4-nitrophenol.
The original Substrate a-(4-nitrophenyl)-ma!toside
was highly insensitive toward the activity of sera (l,
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2), and the preparation of 4-nitrophenyl-a-oligosac-
charides (3, 4) remained difficult till the enzymic
synthesis described by Wallenfels et al. (5, 6). But
the use of these Substrates has now become increas-
ingly populär; and, äs denoted by a series of ab-
stracts (7—17), it has resulted in the production of
test kits, whose components cannot be obtained se-
parately. Hence a systematic evaluation of the ana-
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lytical variables is impossible. The following investi-
gation is a test of the reliability of two chromogenic
α-amylase assays in comparison with other commer-
cially available test kits.
Materials and Methods
A p p a r a t u s and reagents
Absorbance measurements were niade with a Hg-Iine photometer
1101 M Eppendorf, and the reaction rates were monitored at 334,
365 and 405 nm with a potentiometric recorder 4412 (both from
Netheler & Hinz, Hamburg, Germany). While the spreading of
the absorbance (b = 200 mm representing Ao-Ai.o) was kept
constant, the velocity of the recorder chart (v = χ mm/min) was
adjusted so that the slope of the reaction rate curve versus time
remained between 14 and 40° to minimize errors in measuring the
angle and its resulting tan a. All data originated from duplicates
that differed not more than Γ. The catalytic concentration was
calculated according to
v 106 FV
U/l = tana--- —---f
from tan a, v, b, molar absorption coefficient (ε in l · mol"1 · mm^1),
path length of the cuvette (d = 10 mm), f (a dilution factor for
samples with high activities), final (FV) and sample volume (SV).
We investigated clear, lipaemic and icteric'sera immedi tely after
blood clotting and urine specimens within four hours after micturi-
tion. Following tests were applied:
(A) Hydrolysis of4-nitrophenyl oligosaccharides involving the ac-
tion of a-glucosidase:
(1) BM α-Amylase Enzymatic Colorimetric Test® (Boehringer,
Mannheim, Germany; (17)) with 4-nitrophenyl-a-D-malto-
heptaoside and
(2) Testomar®-Amylase (Behringwerke AG, Marburg, Ger-
many) or Pantrak™ E. K. Amylase (Calbiochem-Behring
Corp., La Jolla, CA 92037; (l 1-15)) with 4-nitrophenyl-a-
D-maltopentaoside plus 4-nitrophenyI-a-D-maltohexaoside.
(B) Cleavage of maltotetraose with maitose phosphorylase, -
phosphoglucomutase and glucose-6-phosphate dehydroge-
nase s auxiliary enzymes in Monamyl-neu® (Biomed, M n-
chen, Germany) or Amylase-DS® (Beckman Instruments
Inc., Carlsbad, CA 92008; (18)).
Some properties of α-amylase were comparatively investigated by
an amyloclastic procedure (19), and most of the analytical qualities
of the aforementioned methods were tested with two further kits
based on the formation of glucose by
(C) Degradation of oligosaccharides with subsequent turnover by
a-glucosidase, hexokinase and glucose-6-phosphate dehy-
drogenase:
1l) BM a-Amylase UV-Test® (Boehringer; (20)) with maltohep-
taose and
(2) M+D-UV-Amylase® (American Hospital Supply, M n-
chen, Germany; (21) modified according to I.e. (22)) with
oligosaccharides (and removal of endogenous glucose).
Human salivary and pancreatic amylase were isolated s previously
described (23). We used ct-glucosidases (α-D-glucoside glucohyd-
rolase, EC 3.2.1.20) from human renal cortex s a particle free
homogenate supernatant (100000 g χ 60 min) and from yeast
(Boehringer, Mannheim). Both proved free from α-amylase activi-
ty and inhibitors when tested by an amyloclastic method (19). 4-Ni-
trophenol was twice recrystallized from water. Enzymes were puf-
chased from Boehringer (Mannheim) and all other chemicals from
Merck (Darmstadt, Germany) in best available grade, except Ac-
arbose1) and the infusion Solutions of various producers.
1
l) We are indebted to Dr. W. Puls (Bayer AG) for the generous
gift of Acarbose (BAY g5421).
Procedures
We prepared all reagents with doubly distilled water. The molar
absorption coefficients of 4^nitrophenol were determined from
500 μπιοΐ/ΐ Solutions in buffers according to the specification of
the manufacturers. Temperature and pH-value were controlled
within the cuvette in assays without and with addition of human
serum albumin corresponding to the volume ffraction of the sam-
ple.
To check the influence of drugs and metabolites on the enzyme
assay we added these substances instead of (positive interference)
and in addition to the sample (negative interference). All-determi-
nations were carried out manually with sample volurhes of 20 μΐ
(AI, A2, B) or 10 μΐ (Cl, C2) s micromethods acording to the kit
inserts.
To compare results obtained with the individual methods, we sed
nonparametric techniques (Wilcoxon's signed rariks test), t-test
for paired samples and parametric tests after log transform tioh of
the data to achieve a Gaussian distribution.
Results and Discussion
Influence of the reaction mixture on activity calcula-
tions
The molar absorptivity of 4-nitrophenol between pH
6.5 and 8.0 was highly dependerit on small variations
of hydrogen ion concentration, temperature and sam-
ple constituents. The val es for 8405 nm differed with
respect t the protein content of the reaction mixture;
e.g. the presence of albumin slightly increased the
absorbance in N-2-hydroxyethylpipefazine-N—
ethanesulphonic acid, whereas the absorbance in
phosphate was markedly diminished (tab. 1). Those
effects were not negligible s stated by others (26).
This has to be considered when comparing results
from sera, diluted sera and other biological fluids.
Probably, the biosynthesis of ω'hίtΓOStyryl glucosides
might minimize this problem because of the high ab-
sorption of the liberated chromophore above pH 5.0
(27).
Reaction rates
The reaction lag phases decreased with increasing
temperature and apparently varied with the iriatrix of
the sample (tab. 2). Nevertheless, in contrast to amy-
loclastic techniques (19), there always remained a
short time of delayed catalysis, which can be most
probably ascribed to the properties of the auxiliary
enzymes or to their inhibition by low molecular
weight constituents. In particul r, the extended lag
phases in urines with bacterial contamination were
reduced by dialysis of the specimens against potassi-
urn phosphate, 5 mmol/1, pH 7.5. Dilution of the
specimen was less effective,
Even after the lag phase the catalytic concentrations
of sera, sterile urines and control m teri l varied
slightly, depending on the reaction time. These differ-
ences originating from various determinations be-
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Tab. l. Molar absorption coefficient of 4-nitrophenol (mean and
Standard deviation from 10 determinations) in comparison
with reported values. Human serum albumin, 1.92 g/l,
corresponds to 50 g/l within the sample. For further details
see methods.
Tab. 2. Reaction lag phases of α-amylase from different origins at
25 °C and 30°C.
Conditions
Potassium phosphate,
50 mmol/1
Tenv
pera-
ture
25 °C
30 °C
£405 nm
(1-mor1·
x±SD
981 ±6
1025 ±6
mm~ J )
re-
port-
ed
Ref-
er-
ence
sodium Chloride, 50 mmol/1
pH 7. l
Potassium phosphate, 25 °C 941 ± 5 900 (17)
50 mmol/1 30 °C 952 ± 5 950
sodium chloride« 50 mrnol/l
human serum albumin, l .92 g/I
pH 7. l
N-2-Hydroxyethylpiperazine- 25 eC 804 ± 4 800 (24)
N'-ethancsulphonic acid, 30 °C 808 ± 4 800
48 mmol/1
pH 7.0
N-2-Hydroxyethylpiperazine- 25 °C 810 ± 5
N'-ethanesulphonicacid, 30°C 828 ± 8 870 (15)
48 mmol/1
sodium chloride, 48 mmol/1
human serum albumin, 1.92 g/l
pH 7.0
Sodium hydroxide, 10 mmol/1 25 °C 1835 ± 10 1838 (25)
Sodium hydroxide, 30 °C 1845 ±10 1848 (24)
100 mmol/1
4-nitrophenyl-cx- 4-nitrophenyl-a- Malto-
D-malto- O-malto- tetraose
heptaoside pentaoside/
hexaoside
(AI) (A2) (B)
Pancreatic
amylase
25 °C
30 °C 2
Salivary
amylase
25 °C
30 °C
Normal sera
(n = 10)
25 °C 7 ±
30 °C 5 ±
Macroamylase
sera (n = 5)
25 °C 4 ±
30 °C 3 ±
Urines(n= 10)
25 °C 7 ±
30°C 5±
Precinorm U®
(porcine
pancreatic
amylase)
25 °C
30 °C
3min
.5min
4min
3min
1 min
1 min
1 min
1 min
1 min
1 min
7min
5min
3min
2.5min
5 min
2.5min
7 ± 1 min
5 ± 1 min
5 ± 1 min
3 ± 1 min
7± 1 min
5 ± 1 min
6min
4min
4 min
2 min
7min
3min
10 ±2 min
8 ± 1 min
8 ± 2min
6 ± 1 min
Π ± 3min
8 ± 1 min
10min
6min
tween 5 and 20 min of reaction were rather small on
average, but were sometimes significant (tab. 3).
Therefore, all further calculations were based on
measurements between 15 and 20 min of incubation
with maltoheptaose and oligosaccharides and be-
tween 10 and 12 min with the othef Substrates. The
concentration of α-amyl se obviously did not cause
these variations.
Interferences
Previous studies (4, 28—30) demonstrated that mea-
surements of α-amylase via NADH formation were
affected by α-glucosidase and by some metabolites,
especially in urines. However, the quality of those
test kits has improved, and only a few batches of test
B (maltotetraose) were susceptible to pyruvate, 2
Tab. 3. Relative catalytic concentration of α-amylase in sera at 25 °C. The data were derived from measurements of 25 sampies at different
intervals from the start of the reaction (10 min = 1.000): mean ± Standard deviation, probability of error (two sided tested) of
differences between values at 10 min and other reaction times.
Substrate
(test)
4-Nitrophenyl-a-D-malto-
heptaoside(A 1)
4-Nitrophenyl-a-D-malto-
pentaoside and -hexaoside (A 2)
Maltotetraose (B)
Maltoheptaose (Cl)
Time of measurement afteraddition of the sample
5 min Range at 1 0 min
0.991 ±0.001
p<0;001
0.983 ± 0.002
p < 0.05
0.988 ± 0.003
p < 0.02
not determined
28.3-1410U/ldilution
above500U/l
13.3- 1600 U/l dilution
above500U/l
11. 4-408 /1 dilution
above250U/l
25.0- 1580 U/l dilution
above500U/l
15min
1.01 3 ±0.002
p < 0.20
1.022 ±0.003
p < 0.10
1.008 ±0.003
p < 0.40
1.032 ±0.003
p < 0.005
20min
1.001 ±0.004
p < 0.40
1.01 2 ±0.003
p < 0.40
1.010 ±0.002
p < 0.40
1.040 ±0.003
p < 0.005
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mmol/K which decreased normal amylase values by
nearly 10%. We did not observe any interference by
fructose or acetoacetate in all methods presented in
table. 4. The slight decrease of 4-nitrophenyl-a-£>-
maltopentaose/-hexaose hydrolysis by glucose, 55
mmol/1, paralleled that of 4-nitrophenyl-a-D-mal-
totetraose (16) and could be overcome by an in-
creased Substrate supply. The inhibitory effect of hy^
droxyethyl starch must be considered in view of the
long known adsorption of α-amylase by starch (31).
Since the lag phase of the reaction sequence releas-
ing 4-nitrophenol largely depends on the concentra-
tion of α-glucosidase within the assay System (32, 33,
34), we tried to abridge this phase by addition of a-
glucosidase from yeast. However, neither the lag
phase nor the net absorbance increase in the linear
portion of the activity curve were influenced by this
enzyme up to 250 k U/l within the assay mixture,
thus confirming the observations of David (32) and
Rauscher et aL (17) who used 4-nitrophenyl gluco-
sides for the measurement of α-amylase activity. The
same was true for the hydrolysis of maltoheptaose in
test Cl and that of oligosaccharides in test C2,
whereas the apparent α-amylase concentration was
overestimated by 10% in the maltotetraose proce-
dure, probably by the increased production of mai-
tose from maltotetraose (30).
α-glucosidase from human kidney did not influence
the tests A-C, even in concentrations up to 60 U/l
within the sample, thus exceeding the normal r nge
of 2-23 U/l (35) in human urine. Only extreme con-
centrations, which might be encountered in acute re-
nal necrosis, interfered in the release of 4-nitrophen^
l: 677 U/l of α-glucosidase, determined according
to Bonini et al. (36), were determined s 76.3 U/l
(test AI) or 35.1 U/l (test A2) of α-amylase.
From experiments with porcine enzymes (37), acar-
bose is known to be a more potent inhibitor of mal-
tase and sucrase then of a-amylafse. Suehiro et al.
(38) repofted a noncornpetitive Inhibition of human
amylases by acarbose, a complex oligosaccharide,
which might be possibly resorbed in minimal concen-
trations from the gut. Therefore, after an incubation
with acarbose, 20 mg/1, at 25 °C for 20 min, the re-
sidual activities of purified human amylases (mea-
sured with starch in an amyloclastic method (19))
and of α-glucosidases from yeast (determined with
4-nitropheriyl-a-D-glucopyranoside, 2 mmol/1, in
N-2-hydroxyethylpiperazine-N/-ethanesulphonic
acid, 50 mmol/1 pH 7.0 and potassium phosphate, 50
mmol/1, pH 7.1, corresponding to the buffers of tests
AI and A2) were assayed: 0.94 of α-glucosidase, but
only 0.43 of pancreatic and 0.66 of salivary α-amy-
lase activity were retained. In the presence of acar-
bose, 240 mg/1, the residual activities ainounted to
0.93, 0.03 and 0.09, resp., i.e. acarbose preferential-
ly acted on α-amylase, while its influence on the aux-
iliary enzyme in glucosidase-mediated assays was
minimal.
Specificity
The 4-nitrophenyl glucosides used in tests AI and
A2 were neither hydrolysed by sera whose amylase
activity was abolished by etKylenediaminetetraacetic
acid, 2 mmol/1, nor by 80 U/l of a-mannosidase, a-
Tab. 4. Influence of diverse metabolites and infusion media on four α-amylase assays.
The first figure indicates the effect of the solution tested (20 μΐ instead of serum) on the assay System (control: water = 0). The
second number denotes the influence of the interfering substance on the determination of o^amylase at 25 °C (control: serum =
1.0).
4-NitrophenyI-a-Z)-
maltoheptaoside
(AI)
4-Nitrophenyl-cc- -
maltopentaoside/
hexaoside
(A 2)
Maltotetraose
(B)
Maltoheptaose
(Cl)
Serum
Pyruvate, 2 mmol/1
Lactate, 10 mmol/1
Maltose, 5 mmol/1
Glucose, 10 mmol/1
55mmol/l
Thomadex40®,80g/l
y aemaccel®, 7 g/l
Hydroxyethyl starch, 20 g/l
Mannitol,40g/l
Aminomel LX6®, 16 g/l1)
288 U/l
0
0
0
0
0
0
0
0
0
0
0.99
1.02
1.02
1.01
1.01
0.99
1.02
0.83
0.93
1.0
146 U/l
0
0
0
0
0
0
0
0
0
0
1.01
0.99
0.95
1.0
0.95
0.97
0.98
0.79
0.97
0.98
86.3 U/1
0
0
0
0
0
0
0
0
0
0
0.9-1.0
0.98
1.0
1.0
0.98
0.96
0.96
0,68
0.93
0.90
295 U/l
0
0
0.02
0
0
0
0
0
0
0
1,01
0.97
0,97
1.Ό
0.94
liO
0.99
0.90
0.97
1.01
') contains malate 34 mmol/I, L-amino acids, KC1, Mg(CH3COO)2 and NaOH
J. Clin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 7
Lorcntz: -Amylase assays with nitrophenyl oligosaccharides 467
galactosidase, ß-galactosidase and ß-glucosidase,
added to the reaction mixture.
Table 5 summarizes the relative activities of human
-amylases measured by different methods. These
Tab. 5. Intermethod comparison of relative reaction rates of crys-
tallized human a-amylases (23).
The relative activity of the pancreatic isozyme at 25 °C was
fixed to 1.00 in all assays, the relative activity of salivary
amylase to 1.00 in lest B with maltotetraose. The ciphers
mark conversion factors for 30 °C and 37 °C, activity ratios
(pancreatic amylase/salivary amylase), activation energies
(according to the empirical Arrhenius equation), and Qio
values (calculated from measurements between 25 °C and
37 °C).
25 °C 30 °C 37 °C Activa-
tion
energy
(kJ/mol)
Qio
4-Nitrophenyl-a-O-maltoheptaoside (A 1)
Pancreas
Saliva
Ratio P/S
1.00
0.68
1.47
1.29
0.76
1.70
1.53
0.88
1.74
27.3
17.0
1.431)
1.251)
4-Nitrophenyl-a-D-maltoperitaoside/-hexaoside (A 2)
Pancreas
Saliva
Ratio P/S
1.00
0.68
1.47
1.27
0.74
1.72
1.58
0.94
1.68
29.2
20.6
1.461)
1.31
Maltotetraose (B)
Pancreas
Saliva
Ratio P/S
Starch(19)
Pancreas
Saliva
Ratio P/S
1.00
1.00
1.00
1.00
0.40
2.50
1.32
1.18
1.12
1.18
0.52
2.29
1.80
1.57
1.15
. 1-45
0.72
2.03
37.7
28.7
23.7
37.2
1.63
1.45
1.36
1.62
Linearity between 30 °C and 37 °C uncertain
results support findings of Meier et al. (29) and of
Sampson et al. (39), who observed that maltote-
traose was attacked equally by salivary and pancrea-
tic amylase, whereas starch favoured the action of
the pancreatic isozyme. The nitrophenyl oligosac-
charides held an intermediate position with relative
low activation energies for salivary amylase. From a
diagnostic point of view a Substrate with a long car-
bohydrate chain would be desirable to minimize the
attack by extrapancreatic amylases.
The same problem occurred with control sera äs al-
ready stated for some other Substrates (29, 40). Ta-
ble 6 lists the differences of relative reaction veloci-
ties among control materials from human, porcine,
and bovine sources, viz. the rapid breakdown of ni-
trophenyl glucosides by sera of animal origin and the
slow breakdown by human specimens. Implications
for the quality control of -amylase assays have been
previously reviewed by Bretaudiere et al. (41).
Analytical ränge, accuracy and precision
The manufacturers' Claims for linear response in mi-
croassays with sera could be verified on the whole.
We observed zero-order kinetics up to 1000 U/l (7.7
times the upper reference ränge) for test AI with 4-
nitrophenyl-a-D-maltoheptaoside at 25 °C. The cor-
responding limits were 370 U/l (7.4 times) for test
A2 using 4-nitrophenyl-a-D-maltopentaoside/-
hexaoside, 300 U/l (8.6 times) for test B with mal-
totetraose, 890 U/l (7.1 times) for test Cl with mal-
toheptaose, and 1000 U/l (10 times) for test C2 with
oligosaccharides. On the other hand, the sample vo-
Tab. 6. Intermethod comparison of -amylase assays with quality-control specimens at 25 °C.
The relative activities are presented in reference to results obtained with the maltotetraose method (test B = l .0). The ciphers in
brackets indicate their relative deviation from the assigned values (= 1.00, no assigned value = —).
4-Nitrophenyl-a-D-
maltoheptaoside
(AI)
4-Nitrophenyl-a-O-
maltopentaoside/
hexaoside
(A 2)
Maltotetraose
(B)
Maltoheptaose
(Cl)
Control serum and batch no.
PrecinormU®l-572
PfecinormE®l-366
PrecipathE®5-338
MoniirolI-E®1641)
MonitrolII-E®641)
ValidateN®2018090J)
HylandP®P21B
VersatolE®4H726
Kontrollogen LP® 623205 A1)
Kontrollogen L® 623 1 161)
Enza-TroI®ET247A
Seronorm® 147
ip.i
J6.7
17.3
3.73
4.22
3.78
10.5
10.4
3.60
3.63
16.6
12.6
(1.08)
(1.08)
(1.07)
(1.06)
(1.05)
(1.04)
(1.07)
(1.05)
(1.05)
(1-15)
(1.18)
(1.09)
5.23 (-)
8.80 (-)
8.94 (-)
1.65 (-)
1.91 (-)
1.77 (-)
5.44 (-)
5.59 (-)
1.63 (-)
1.55 (-)
7.51 (-)
6.81 (-) 1
1.0
1.0
1.0
1.0
.0
.0
.0
.0
.0
.0
.0
t.O
i-!
(1.04)
(1.04)
(1.14)
(— )
(1.10)
(1. )
(1.05)
(1.00)
9.35
15.5
16.2
3.43
4.11
3.96
9.97
9.65
3.46
3.49
14.4
12.2
(1.00)
(1.00)
(1.00)
(0.94)
(1.03)
(1.09)
(1.01)
(0.97)
(1.00)
(1-11)
(1.06)
(1.06)
J) Material of apparently human origin
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lume fraction noticeably influenced the measured
catalytic concentration only in tests with nitrophenyl
glucosides. A ratio of sample volume to final volume
of 1/51 yielded 8 ± 3% (n = 25) higher values than
a 1/26 ratio. This agreed well with observations in
highly active sera after dilution with sodium chlo-
ride, 155 mmol/1. By dilution of serum with l part of
saline the relative activity increased from 1.0 to 1.12
± 0.04 (AI: 4-nitrophenyl-a-D-maltoheptaoside, n
= 8) and 1.04 ± 0.02 (A2: 4-nitrophenyl-a-D-mal-
topentaoside/-hexaoside, n = 8), by dilution with 9
parts of saline the respective data were 1.18 ± 0.07
and 1.06 ± 0.05. A dilution with potassium phos-
phate, 50 mmol/1, pH 7.1 (for test AI) or N-2-hy-
droxyethylpiperazine-N'-ethanesuIphonic acid, 50
mmol/1, pH 7.0 (for test A2) produced identical
values, which proved significantly different (p
<0.05) from the original relative activities. This was
at variance with results obtained when human serum
albumin, 50 g/l, was used äs a diluent. With both
tests AI and A2? only a small increase was observed:
to 1.02 ± 0.04 with a l plus l and to 1.05 ± 0.05
with a l plus 9 dilution.
Therefore, the stronger dilution effects of saline and
buffer in test AI were attributed to the higher ab-
sorption coefficient of 4-nitrophenol in phosphate
buffer with decreasing protein concentrations äs re-
ported above. The opposite effect in N-2-hydroxye-
thylpiperazine-N' -ethanesulphonic acid evidently
compensated to some extent the dilution of <x-glüo
osidase Inhibitors in both tests. This was concluded
from a small rise of activity to 1.03 ± 0.04 by dilu-
tion with 9 parts of saline, phosphate buffer or hu-
man serum albumin in test Cl with oligosaccharides,
while both the maltotetraose and the amyloclastic
methods were not affected.
Tab. 7. Imprecision of -amylase assays with 4-nitrophenyI-a-D-
glucosides in manual performance at 25 °C. For further
details, see methods.
Human serum pool 4-Nitrophenyl-
a-D-malto-
heptaoside
(AI)
Mean, CV,
U/l %
4-Nitrophenyl-
ct-D-malto-
pentaoside/
hexaoside
(A 2)
Mean, CV,
U/l %
Normal ränge
Upper reference ränge
Pathological ränge
Normal ränge
Upper reference ränge
Pathological ränge
Imprecision within-run (n = 30)
65.2 3.62 27.9 3.38
139 3.63 59.3 2.95
491 2.54 216 2.86
Imprecision day-to-day (n = 20)
66,4 3.87 28.5 4.04
145 3.19 60.6 2.79
494 2.94 218 3.06
The accuracy of four tests was checked with control
sera whose assigned values were taken äs 1.00. The
corresponding data giveil in table 6 showed a slight
positive bias of about 6% on average. This might
originale from an iiiaccufate sample volume in the
micromethod used. Table 7 summiarizes the results
of precision studies with chromogenic tests AI and
A2. Their imprecision was equal to that of the mal-
totetraose procedure (30), but less than that of as-
says with maltoheptaose and oligosaccharides. Their
coefficients of Variation (human serum pool in the
pathological ränge, within-run, n = 30) were 3.22%
for test Cl arid 6.32% for test C2, pföbably due to
their smaller sample volumes. In general the results
agreed well with those reported recently (4, 17, 42,
43).
Stability of reagents and intrinsic sensitivity
The cleavage by -glucosidase of glucosides and 4-
nitrophenyl glucosides increases with decreasing
chain length of the Substrate (32, 33). Since a-gluc-
osidase degrades the original Substrates to smaller
ones which are then hydrolysed more räpidiy, the
blank reaction accelerates with time after mixing
Substrate with auxiliary enzyme (tab. 8). Test AI is
also proffered with 4-nitrophenyl maltoheptaoside
and a^glucosidase in separate vials. Nevertheless,
even Solutions ready for use containing nitrophenyl
glucosides may be stored for 48 h ät 4 °C or for 8 h at
25 °C if proper corrections are made for the blank
reaction. We obtained identical results iii assays with
reagents just reconstituted, arid with Solutions kept
Tab. 8. Blank reaction rates of three ct-glucos'idase-mediated a-
amylase assays.
The change of absorbance per hour was recorded during
different periods after preparihg the reagent containing
Substrate, auxiliary enzyme, buffer, and sodium Chloride.
Period
4°C
3- 4h
7- 8h
23-24 h
47-48 h
25 °C
0- 1h
3- 4h
7- 8h
11'-= 12 h
15-16h
4-NitfophenyU
o^D-malto^
heptaoside
(AI )
AA4o5/h U/l
0.002
0.008
0.012
0.031
0.009
0.018
0.031
0.042
0.050
0.289
1.16
1.73
4.48
1.30
2.60
4.48
6.07
7.22
4^Nitfophenyl·
pentaoside/
hexaoside
(A2)
AAWh U/l
0.001
0.002
0.008
0,020
0.009
0.023
0.041
0.052
0.061
0.054
0.108
0.433
1.08
0.488
1.25
2.22
2.82
3.3p
Malto-
heptaose
(Cl) '
AA366/h Ü/l
0.020
0.030
0.048
0.071
'·<
0.062
0.096
0.124
0.156
0.194
3.30
4.95
7.92
11.7
10,2
15.8
20,5
25.7
32.0
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as described above for a-amylase concentrations up
to 500 U/l with test AI and up to 200 U/l with test
A2. On the other hand, the blank reaction of test C2
(not shown in table 8) was 16.6 ± 2.4 U/l (n = 10)
immediately after preparing the reagent.
Concerning the quantitative signal, calculated in ΔΑ
• l · μπιοί""1 (i.e. Δ A/min per U/l for an identical
final to sample volume ratio), there was no essential
difference in sensitivity between the cleavage of mal-
totetraose and the hydrolysis of chromogenic sub-
strates. Taking test B with maltotetraose (334 nm) s
1.00, the relative intrinsic sensitivities were 1.00 ±
0.03 for 4-nitrophenyl-a-D-maltoheptaoside (405
nm), 1.09 ± 0.05 for 4-nitrophenyl-a-D-maltopen-
taosideAhexaoside (405 nm), 6.69 ±0.10 for malto-
heptaose (334 nm) and 3.57 ± 0.26 for oligosaccha-
rides (334 nm) derived from the determination of 10
sera (x ± s) over a wide r nge of α-amylase concen-
trations.
2000
«Λ g
.ο e —.
3 · <U
CO Ό
- £ g 1000
ι o
s - "
J2 <
>> JC
^ e 500
1000 50003000
a-Amylase
(Substrate: 4-ni t rophenyl-a- /7-maliohepiaoside)[U/l)
Fig. l. Comparison of α-amylase determination by 4-nitrophenyl-
α-D-maltoheptaoside (AI, abscissa) and 4-nitrophenyl-a-
D-maltopentaoside/-hexaoside (A2, Ordinate) with 120
sera at 25 °C: r = 0.996, y = 0.379x + 5.69 (standardized
main component: y = 0.377x + 5.35).
Intermethod comparison
A practical evaluation was carried out with a total of
180 sera including lipaemic, icteric and haemolytic
specimens and with 50 urines of healthy and diabetic
persons. Both chromogenic methods were insensi-
tive to lipaemia even with chylous samples contain-
ing 50 mmol/1 of triglycerides; they were also insen-
sitive to bilirubin up to 280 μηιοΐ/ΐ in icteric sera and
to haemoglobin concentrations between 0.5 and 2.7
g/l. As in the test with maltotetraose, both chromo-
genic methods were only limited by the capability of
the photometer to measure high absorptivities. In
urines glucose up to 330 mmol/1, after appropriate
dilution to 170 mmol/1 for test AI and 112 mmol/1
for test B, did not influence these assays, whereas a-
amylase concentrations in test A2 were underesti-
mated by about 7%, hence requiring a further dilu-
tion.
A comparative determination of α-amylase activity
at two temperatures with 24 sera ranging from 19.6
to 642 U/l (test B, 25 °C) yielded 30 °C/25 °C ratios
from 1.26 ± 0.11 (test AI) and 1.26 ± 0.10 (test
A2) to 1.34 ± 0.09 (test B) thus«reflecting the pre-
ponderance of the pancreatic isozyme in those speci-
mens (see tab. 5).
Table 8 presents a survey of all statistical data from
parallel investigations of sera and urines with differ-
ent methods. For regressipn analysis the data under-
went log transformation because of their apparent
log-Gaussian Distribution in all assays. Their correla-
tion was fairly g od as shown graphically (fig. l and
2), and correlation coefficients calculated by nonpa-
rametric tests, like those from parametric tests (tab.
4S 250
1^200
o ·—.
f ς; 150
^ ·»
uo ci Έ
~ ? i
s -s. s 100
ε so
100 500300
a-Amylose
(Substrate: 4 -nitrophenyl -cc-D- maltoheptaoside)lU/l]
Fig. 2. Comparison of α-amylase determination by 4^nitrophen-
yl-a-O-maltoheptaoside (AI, abscissa) and 4-nitrophen-
yl-a^D-maltopentaoside/-hexaoside (A2, Ordinate) with
45 urines at 25 °C: r = 0.970, y = 0.383x + 1.79 (stand-
ardized main component: y = 0.391 χ — 0.461).
8) (Wilcoxon's signed ranks test and Spearman's
rank correlation) were also above 0.910. However,
we rarely detected urines which displayed extremely
low α-amylase activites in the maltotetraose proce-
dure but quite normal values with all techniques em-
ploying α-glucosidase. Hence, in these cases we pre-
sumed erroneous results with the maltotetraose
procedure due to the presence of inhibitors which
were dialysable but not yet identified.
Conclusions
To characterize in brief the essential qualities of a-
amylase measurements with nitrophenyl glucosides,
it can be stated that these Substrates offer advantages
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of shorter lag phases and a lack of dependence on
NADH producing and consuming metabolites and/
or enzymes of the sample, thus yielding a real, low
and constant blank rate, which cannot always be
guaranteed by other methods (30). Moreover the
unfavourable preference of the salivary isozyme by
the maltotetraose procedure is reduced even though
not abolished by the use of nitrophenyl glucosides
that are more sensitive to animal amylases.
As for linear reaction rates (concerning dilution
r nge and duration of measurement) all assays com-
pared are almost equal. α-Glucosidase seems to be
more resistant to some inhibitors that very occasion-
ally in urines than the three-step enzyme System of
test B. However, the chromogenic Substrates present
Problems in the measurement of highly active sera,
mostly due lo the influence of protein on the absorp-
tivity of 4-nitrophenol. Further, their defined degra-
dation products (34) might change with reaction me-
dium and samplexonstituents. Although these meth-
ods have promoted a definite progress in the assay of
α-amylase, two postulates from our expert group
(44) are still far from realization, viz. the absence of
lag phases and of deviations from linearity.
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Tab. 9. Intermethod comparison of α-amylase assays at 25 °C
The ciphers denote: r nge of values for different materials
(U/l with test B), number of paired samples (n), linear
regression equation with test B (maltotetraose method) s
independent variable χ (slope and y-intercept), and Pear-
son correlation coefficient (r).
. _
Range of n Dependent variable Regression r
values equation
U/l y y = ax + b
Clearsera
5.4-902 135 4-Nitrophenyl-a-D- y = 4.71x-27.6 0.926
maltoheptaoside
(AI)
5.4-902 135 4-Nitrophenyl-a-D- y = 1.80x-4.81 .0.932
maltopentaoside/
hexaoside (A 2)
5.4-902 135 Maltoheptaose (C J) y = 4.78x + 5.60 0.991
5.4-902 135 Oligosaccharides y = 3.92x-12.1 0.993
(C2)
Lipaemic sera (Triglycerides 4.10-51.4 mmol/1)
15.9-197 10 4-Nitrophenyl-a-D- y = 5.48x-57.0 0.983
maltoheptaoside
(AI )
15.9-197 10 4^ΝίΐΓορη^Ι-α-Ρ- y = 2.15x-18.1 0.986
maltopentaoside/
hexaoside (A 2)
Icteric sera (Bilirubin 26.3-283 μηιοΐ/ΐ)
16.9-115 10 4-Nitrophenyl-a-D- y = 6.03x-39.5 0.996
maltoheptaoside
(AI )
16.9-115 10 4-Nitrophenyl-a-D- y = 2.02x-6.21 0.999
maltopentaoside/
hexaoside (A 2)
Urines (Glucose 0-330 mmol/1) ... ^
4.7-120 40 4-Nitrophenyl-a-D- y = 4.25x4-8.68 0.909
maltoheptaoside
(AI)
4.7-120 40 4-Nitrophenyl-a-D- y= 1.84x + 2.18 0.979
maltopentaoside/
hexaoside (A 2)
4.7-120 40 Maltoheptaose (C l) y = 4.90x + 12.1 0.970
4.7-120 40 Oligosaccharides y = 3.36x + 18.8 0.980
(C2)
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